世界卫生组织自助心理干预预防土耳其境内叙利亚难民精神障碍的效果:一项随机对照试验
该两臂、评估者遮蔽随机对照试验在土耳其两个地区纳入642名有心理困扰但无精神障碍诊断的成年叙利亚难民,比较自助 Plus(联合强化常规照护)与仅强化常规照护。自助 Plus 组在6个月随访时任何精神障碍发生率显著低于对照组(21.69% vs. 40.73%;风险比0.533,95%CI 0.408-0.696)。干预后即刻未见效果,但6个月随访时抑郁症状、个人确认的心理结局和生活质量有有益效应。
要点
- 自助 Plus 组6个月随访任何精神障碍发生率21.69%,对照组40.73%(风险比0.533,95%CI 0.408-0.696)。
- 干预后即刻自助 Plus 对次要结局未显示有效,6个月随访时抑郁症状、个人确认心理结局和生活质量有有益效应。
- 作者认为该低强度自助心理干预可作为公共卫生策略在持续逆境中的难民群体中扩大实施以预防精神障碍。
核心结论
- 自助 Plus 是预防有心理困扰但无精神障碍诊断的叙利亚难民发生精神障碍的有效策略。
- 作者认为该低强度自助心理干预可作为公共卫生策略在持续逆境中的难民群体中扩大实施以预防精神障碍。
研究设计与样本
- 两臂、评估者遮蔽随机对照试验,在土耳其两个地区开展。
- 纳入标准为有心理困扰(一般健康问卷≥3)但无精神障碍诊断的成年叙利亚难民。
- 2018年10月1日至2019年11月30日评估1186名难民,544名不符合条件,642名入组并随机分配至自助 Plus 组(N=322)或强化常规照护组(N=320),比例1:1。
- 自助 Plus 由两名促进者以小组形式实施,共五次课程。
- 主要结局为6个月随访时采用简易国际神经精神访谈评估的任何精神障碍;次要结局包括干预后精神障碍、心理困扰、创伤后应激障碍症状、抑郁症状、个人确认的心理结局、功能损害、主观幸福感和生活质量(干预后及6个月随访)。
主要发现
- 6个月随访时,自助 Plus 组任何精神障碍发生率21.69%,强化常规照护组40.73%(Cramer's V=0.205,p<0.001,风险比0.533,95%CI 0.408-0.696)。
- 次要结局分析提示自助 Plus 在干预后即刻无效,但6个月随访时在抑郁症状、个人确认的心理结局和生活质量方面有有益效应。
关键数值与推荐
- 纳入标准:一般健康问卷≥3分且有心理困扰但无精神障碍诊断的成年叙利亚难民。
- 主要结局:6个月随访时简易国际神经精神访谈评估的任何精神障碍。
- 自助 Plus 组6个月随访任何精神障碍21.69% vs. 强化常规照护组40.73%(风险比0.533,95%CI 0.408-0.696)。
临床怎么用
- 作者认为该低强度自助心理干预可作为公共卫生策略在持续逆境中的难民群体中扩大实施以预防精神障碍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Refugees are at high risk of developing mental disorders. There is no evidence from randomized controlled trials (RCTs) that psychological interventions can prevent the onset of mental disorders in this group. We assessed the effectiveness of a self-help psychological intervention developed by the World Health Organization, called Self-Help Plus, in preventing the development of mental disorders among Syrian refugees experiencing psychological distress in Turkey. A two-arm, assessor-masked RCT was conducted in two Turkish areas. Eligible participants were adult Syrian refugees experiencing psychological distress (General Health Questionnaire ≥3), but without a diagnosis of mental disorder. They were randomly assigned either to the Self-Help Plus arm (consisting of Self-Help Plus combined with Enhanced Care as Usual, ECAU) or to ECAU only in a 1:1 ratio. Self-Help Plus was delivered in a group format by two facilitators over five sessions. The primary outcome measure was the presence of any mental disorder assessed by the Mini International Neuropsychiatric Interview at six-month follow-up. Secondary outcome measures were the presence of mental disorders at post-intervention, and psychological distress, symptoms of post-traumatic stress disorder and depression, personally identified psychological outcomes, functional impairment, subjective well-being, and quality of life at post-intervention and six-month follow-up. Between October 1, 2018 and November 30, 2019, 1,186 refugees were assessed for inclusion. Five hundred forty-four people were ineligible, and 642 participants were enrolled and randomly assigned to either Self-Help Plus (N=322) or ECAU (N=320). Self-Help Plus participants were significantly less likely to have any mental disorders at six-month follow-up compared to the ECAU group (21.69% vs. 40.73%; Cramer's V = 0.205, p<0.001, risk ratio: 0.533, 95% CI: 0.408-0.696). Analysis of secondary outcomes suggested that Self-Help Plus was not effective immediately post-intervention, but was associated with beneficial effects at six-month follow-up in terms of symptoms of depression, personally identified psychological outcomes, and quality of life. This is the first prevention RCT ever conducted among refugees experiencing psychological distress but without a mental disorder. Self-Help Plus was found to be an effective strategy for preventing the onset of mental disorders. Based on these findings, this low-intensity self-help psychological intervention could be scaled up as a public health strategy to prevent mental disorders in refugee populations exposed to ongoing adversities.
引用
- Acarturk C, Uygun E, Ilkkursun Z, et al. Effectiveness of a WHO self-help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial. World Psychiatry. 2022. PMID: 35015365. doi:10.1002/wps.20939
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。